Athletes | Controls | Difference | |
---|---|---|---|
Parameter | p-value | ||
N | 23 | 16 | |
Heart rate (beats * min-1) | 60 (41–79) | 72 (57–100) | < 0.001 |
Septumd (mm) | 10 (7–12) | 9 (7–11) | 0.044 |
LVEDd (mm) | 56 (46–68) | 53 (47–61) | 0.055 |
LVPWTd (mm) | 9.0 (7.0–11.0) | 8.0 (6.0–10.0) | < 0.001 |
LVM (g) | 225 (138–268) | 168.5 (103–231) | < 0.001 |
LVEDd-A4Ch (mm) | 57 (47–67) | 53 (45–60) | 0.005 |
LA-area (cm2) | 20.0 (15.4–24.8) | 17.5 (12.5–24.1) | 0.005 |
RA-area (cm2) | 20.0 (12.1–30.9) | 16.0 (10.5–21.9) | < 0.001 |
3D-LAvolume (mL) | 73 (49–106) | 51 (35–88) | < 0.001 |
RVIT1-A4CH (mm) | 38 (21–45) | 34 (29–45) | 0.053 |
TAPSE (mm) | 27 (17–33) | 26 (22–28) | 0.009 |
RVFAC (%) | 49 (40–58) | 47 (37–55) | 0.086 |
E-velocity (m * s−1) | 0.8 (0.6–1.2) | 0.8 (0.5–1.2) | 0.933 |
A-velocity (m * s-1) | 0.4 (0.3–0.5) | 0.5 (0.4–1.1) | < 0.001 |
EA-ratio | 2.1 (1.5–3.0) | 1.4 (0.9–2.3) | < 0.001 |
e-prim-mean (m * s-1) | 0.17 (0.11–0.24) | 0.17 (0.10–0.19) | 0.746 |
E-eprim-ratio | 5.1 (0.0–6.3) | 5.0 (0.0–7.6) | 0.682 |
2D-LVEDV (mL) | 176 (128–239) | 150 (112–178) | < 0.001 |
2D-LVESV (mL) | 78 (53–114) | 63 (41–77) | < 0.001 |
2D-LVEF (%) | 56 (49–64) | 57 (53–67) | 0.329 |
3D-LVEDV (mL) | 200 (145–245) | 154 (117–195) | < 0.001 |
3D-LVESV (mL) | 80 (60–128) | 67 (40–93) | 0.003 |
3D-LVSV (mL) | 117 (79–148) | 91 (68–107) | < 0.001 |
3D-LVEF (%) | 59 (47–67) | 58 (50–66) | 1.000 |
2D-Echo-tissue-volume ratio | 1 (1–1) | 1 (0–1) | 0.434 |
2D-LVGLS (%) | −19 (−24--15) | − 19 (− 22--14) | 0.362 |
3D-Sphericity | 0.45 (0.33–0.73) | 0.33 (0.24–0.48) | < 0.001 |